ARCHIVES

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 14 | April 2, 1993

Download PDF Visit The Full Archive

Related Articles

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

In Brief: Peagler Heads AACE, Myers Is Presidents Elect; Bottiglieri Retires, Fink To Replace Him At ACS

January 6, 1984

Breast Cancer Report To The Profession Suddenly Is a Report To The Nation; Treatment Progress Noted

October 4, 1974

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976